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Genome-wide association study for response to vaccination in Angus
calves
Abstract
Background: Bovine respiratory disease complex (BRDC) is one of the most important sources of loss within
the beef cattle industry in the USA. Steps have been taken to reduce the incidence of BRDC through
vaccination. Despite the effectiveness of vaccines, large proportions of cattle still experience morbidity and
mortality. Identification of genomic regions that are associated with variation in response to vaccination
would allow for the selection of individuals genetically predisposed to respond to vaccination based on
specific markers, while heritability and accuracy estimates would help facilitate genomic selection. This in turn
may lead to selection for beef cattle herds that may have lower incidence rate of BRDC after vaccination. This
study utilizes an Angus herd of more than 2000 head of cattle to identify these regions of association.
Results: Genome wide association studies were performed for viral neutralization antibody level and response
to vaccination traits against four different viruses associated with BRDC: bovine viral diarrhea virus 1 and 2
(BVDV1 and BVDV2), bovine respiratory syncytial virus (BRSV), and bovine herpesvirus (BHV1). A total
of six 1-Mb windows were associated with greater than 1% of the genetic variance for the analyzed vaccination
response traits. Heritabilities ranged from 0.08 to 0.21 and prediction accuracy ranged from 0.01 to 0.33
across 7 different vaccination traits.
Conclusions: Although six 1-Mb windows were identified as associated with 1% or greater genetic variance for
viral neutralization antibody level and response to vaccination traits, few genes around these windows could
readily be considered candidates. This indicates the need for further functional genomic annotation, as these
regions appear to be gene deserts. Traits ranged from lowly to moderately heritable, which indicated the
potential for selection of individuals that are genetically pre-disposed to respond to vaccination. The relatively
low amount of genetic variance accounted for by any 1-Mb window indicated that viral neutralization
antibody level and response to vaccination traits are polygenic in nature. Selection for these traits is possible,
but likely to be slow due to the low heritabilities and absence of markers with high genetic variation associated
with them.
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Genome-wide association study for
response to vaccination in Angus calves1
L. M. Kramer1 , M. S. Mayes1, E. D. Downey2, R. G. Tait Jr3, A. Woolums4, C. Chase5 and J. M. Reecy1*
Abstract
Background: Bovine respiratory disease complex (BRDC) is one of the most important sources of loss within the
beef cattle industry in the USA. Steps have been taken to reduce the incidence of BRDC through vaccination. Despite
the effectiveness of vaccines, large proportions of cattle still experience morbidity and mortality. Identification of
genomic regions that are associated with variation in response to vaccination would allow for the selection
of individuals genetically predisposed to respond to vaccination based on specific markers, while heritability
and accuracy estimates would help facilitate genomic selection. This in turn may lead to selection for beef
cattle herds that may have lower incidence rate of BRDC after vaccination. This study utilizes an Angus herd
of more than 2000 head of cattle to identify these regions of association.
Results: Genome wide association studies were performed for viral neutralization antibody level and response
to vaccination traits against four different viruses associated with BRDC: bovine viral diarrhea virus 1 and 2 (BVDV1 and
BVDV2), bovine respiratory syncytial virus (BRSV), and bovine herpesvirus (BHV1). A total of six 1-Mb windows were
associated with greater than 1% of the genetic variance for the analyzed vaccination response traits. Heritabilities
ranged from 0.08 to 0.21 and prediction accuracy ranged from 0.01 to 0.33 across 7 different vaccination traits.
Conclusions: Although six 1-Mb windows were identified as associated with 1% or greater genetic variance for viral
neutralization antibody level and response to vaccination traits, few genes around these windows could readily be
considered candidates. This indicates the need for further functional genomic annotation, as these regions appear to
be gene deserts. Traits ranged from lowly to moderately heritable, which indicated the potential for selection of
individuals that are genetically pre-disposed to respond to vaccination. The relatively low amount of genetic variance
accounted for by any 1-Mb window indicated that viral neutralization antibody level and response to vaccination traits
are polygenic in nature. Selection for these traits is possible, but likely to be slow due to the low heritabilities and
absence of markers with high genetic variation associated with them.
Keywords: Accuracy, Beef cattle, Bovine respiratory disease complex, Genome-wide association study, Heritability,
Immune response, Vaccination
Background
Bovine respiratory disease complex (BRDC) is one of the
most costly and pervasive disease conditions facing beef
cattle producers. With more than $750 million dollars in
losses each year due to morbidity, mortality, and per-
formance loss, vaccines have been one method used in
an attempt to reduce overall incidence rates and by ex-
tension economic losses [1–4]. Despite widespread
adoption of vaccination protocols in the beef cattle
industry, BRDC remains extremely prevalent due to
varying levels of vaccine efficacy [5, 6]. Research into re-
sponse to vaccination has identified multiple environ-
mental and management variables which impact an
individual calf ’s ability to mount an antibody response
[7–9]. Factors such as maternally derived antibody levels
from colostrum, calf age, seasonality, and weaning status
all impact a calf ’s individual immune system, and result
in variability in its response to vaccination [10–12].
In order to improve efficacy of vaccination for BRDC, it
is desired that all calves exhibit an adequate immune re-
sponse after vaccination. If this is the case, calves would
likely be better protected against future exposure to BRDC
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viruses after a multi-shot vaccination procedure and
thereby result in less economic loss due to BRDC. One
way to improve beef cattle response to vaccination may be
through genomic selection. Previously, we reported on
variables that influenced response to vaccination against
bovine viral diarrhea virus 1 (BVDV1), bovine viral diar-
rhea virus 2 (BVDV2), bovine respiratory syncytial virus
(BRSV), and bovine herpesvirus (BHV1) [13–15]. A
genome-wide association study was performed on five dif-
ferent responses to vaccination/viral antibody titer traits
across all four viruses (initial titer, final titer, initial vaccin-
ation response [IVR], booster vaccination response [BVR],
overall vaccination response [OVR]) with an additional
two traits analyzed only on BVDV1 and BVDV2 (maternal
decay and maternal antibody titer) due to availability of
data (Fig. 1). Through heritability and accuracy estimates
for response to vaccination and viral antibody titer level
traits, producers would be afforded the opportunity to se-
lect for cattle with higher immune response to vaccin-
ation. As such, the goal of this study was to identify
regions of the genome that were associated with response
to vaccination and viral antibody level and evaluate the
potential for genomic selection for calves with improved
immune response to vaccination as has been done in cat-
tle [16] and other species [17].
Results
Estimates of genetic and residual variance, and
heritability
Estimates of heritabilities and variances were obtained for
each viral antibody titer levels and response to vaccination
traits (Table 1). Heritability (h2) estimates, which were the
proportion of additive genetic variance out of the total
phenotypic variance, ranged from 0.08 to 0.22. The great-
est spread of heritabilities was found within BVDV2 with
a minimum estimated heritability of 0.08 and a maximum
of 0.22. In contrast, BRSV had the smallest spread with a
minimum heritability of 0.12 and a maximum of 0.18. Ma-
ternal decay and maternal antibody titer traits were only
available for BVDV1 and BVDV2. Total genetic and re-
sidual posterior variances were relatively similar across all
viral neutralization antibody level and response to vaccin-
ation traits. Maternal decay of BVDV2 titer level had the
lowest posterior genetic variance (0.005) and residual vari-
ance (0.02). In contrast, no single antibody titer level or
response to vaccination trait had both the highest genetic
and residual posterior variance.
Whole genome association
The amount of genetic variance that every 1-Mb window
across the bovine genome could account for was estimated
Fig. 1 Study sample collection timeline. Colored boxes correspond to data availability of that trait to one of the four viruses. Bovine Viral Diarrhea
Virus 1 (BVDV1) in blue, Bovine Viral Diarrhea Virus 2 (BVDV2) in red, Bovine Respiratory Syncytial Virus (BRSV) in green, Bovine Herpesvirus (BHV1)
in purple. For each virus 3 response variables were calculated: 1) initial vaccination response = booster titer – initial titer; 2) booster vaccination
response = final titer – booster titer; 3) overall vaccination response = final titer – initial titer. For BVDV1 and BVDV2 rate of maternal antibody
decay was calculated: (initial titer – maternal titer) / number of days between initial titer and maternal titer measurements)
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based on the model for a viral neutralization antibody level
or response to vaccination trait. Furthermore, the posterior
probability of inclusion for each SNP and 1-Mb window
was calculated as well. There were no 1-Mb regions across
all viral neutralization antibody level and response to vac-
cination traits for all four viruses that exceeded a 0.9
posterior probability of inclusion. Six 1-Mb windows across
the genome across traits could account for greater than 1%
of the trait genetic variance (Table 2). The percent variance
accounted by these windows ranged from 1.01 to 1.93%.
These six 1-Mb windows were associated with four anti-
body titer levels or response to vaccination traits: two win-
dows for BVDV1 initial titer (Fig. 2), two for BVDV1
overall vaccination response (Fig. 3), one for BVDV2
booster vaccination response (Fig. 4), and the final 1-Mb
window for BRSV overall vaccination response (Fig. 5).
All genes within these windows were evaluated as po-
tential candidate genes. Unfortunately, none of the genes
within these windows were annotated with immune
function Gene Ontology terms. However, higher order
gene families names, e.g. TRIML, may have some func-
tion related to immune system response [18]. Addition-
ally, multiple transcription factors were identified such
as EST1, which may have some functional relationship
with immune response.
Traits were also analyzed categorically, with pheno-
types being set as their integer value. This marginally
improved the heritability of the response to vaccination
and viral neutralization antibody levels (Table 3). How-
ever, in these analyses no windows accounted for greater
than 1% of the estimated genetic variation.
Correlations and accuracies
Individuals were separated into five groups that exhib-
ited high genetic diversity between groups while main-
taining genetic similarity within groups. The number of
individuals in each of the five groups can be seen in
Table 4. Different numbers of individuals were present
in the different clusters between different viral antibody
titer levels and responses to vaccination traits was due
to different numbers of calves with phenotype data and
the presence or absence of various data time points.
BVDV2 was the initial viral antigen studied at the incep-
tion of this study. As such, the individuals that could be
analyzed for the other 3 viral antigens came from a
smaller pool and are therefore more variable in the total
number utilized. The pooled correlation between direct
Table 1 Posterior estimates of genetic (σg2) and residual (σe2)
variance, and heritability (h2)
Virus Traita σg
2 σe
2 h2
BVDV1 Maternal Decayb 0.01 0.03 0.22
Maternal Antibody Titerb 0.28 1.58 0.15
Initial Titer 0.41 1.58 0.21
Initial Vaccination Response 0.17 0.73 0.18
Booster Vaccination Response 0.33 1.42 0.19
Overall Vaccination Response 0.29 1.48 0.16
Final Titer 0.33 1.65 0.17
BVDV2 Maternal Decayb 0.005 0.02 0.21
Maternal Antibody Titerb 0.23 2.03 0.10
Initial Titer 0.17 1.94 0.08
Initial Vaccination Response 0.11 1.16 0.09
Booster Vaccination Response 0.21 2.25 0.08
Overall Vaccination Response 0.18 2.02 0.08
Final Titer 0.20 2.01 0.09
BRSV Initial Titer 0.18 1.38 0.12
Initial Vaccination Response 0.07 0.35 0.16
Booster Vaccination Response 0.09 0.42 0.18
Overall Vaccination Response 0.09 0.47 0.16
Final Titer 0.08 0.49 0.14
BHV1 Initial Titer 0.14 1.24 0.10
Initial Vaccination Response 0.22 1.52 0.13
Booster Vaccination Response 0.29 2.20 0.18
Overall Vaccination Response 0.30 2.28 0.12
Final Titer 0.27 2.36 0.10
aAll trait titers measured in log2 transformations from serum neutralization
dilutions. Maternal Decay measured as log2 titer change per day
bMaternal Decay and Maternal antibody titer data only available for BVDV1
and BVDV2 (Bayes C analysis)
Table 2 1-Mb genomic windows that accounted for greater than 1% genetic variance for response to vaccination traits
Virus Traita Chr_Mbb Starting SNP Ending SNP # of SNP Genetic Variance (%) PPIc
BVDV1 Initial Vaccination Titer 2_24 rs137131604 rs109222292 220 1.64 0.57
18_9 rs43715906 rs29024678 400 1.01 0.65
Overall Vaccination Response 4_12 rs133210106 rs109951163 172 1.93 0.61
29_32 rs43727482 rs137609870 253 1.15 0.51
BVDV2 Booster Vaccination Response 27_16 rs134611614 rs43207573 300 1.03 0.54
BRSV Overall Vaccination Response 1_144 rs109534947 rs42965155 296 1.03 0.49
aAll trait titers measured in log2 transformations from serum neutralization dilutions
b1-Mb window defined by chromosome and mega base position. UMD3.1 build of Bos taurus genome
cPosterior probability of inclusion (inclusion rate in BayesB analysis)
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genetic value estimates and the true phenotype ranged
from − 0.10 for BHV1 overall vaccination response to
0.09 for BVDV1 final titer and overall vaccination re-
sponse. Prediction accuracies ranged from an absolute
value of 0.002 to 0.31 (Table 5). Maternal decay traits for
BVDV1 and BVDV2 were unable to be estimated due to
a failure to converge, and so could not be calculated for
correlation or accuracy.
Discussion
In this study, we set out to identify regions of the gen-
ome that were associated with viral neutralization anti-
body level and response to vaccination traits for four
viruses associated with BRDC. To do so, a genome wide
association study was performed to characterize regions
based on the proportion of genetic variance they could
account for within a trait. Heritability estimates for viral
Fig. 2 Manhattan plot for 1-Mb windows for Bovine viral diarrhea virus type 1 initial titer. A Manhattan plot showing every 1-Mb window by
%variance accounted for by that window across the entire Bos taurus genome. Two singular windows exceeded the 1% genetic variance
threshold: chromosome 2, Mb 24 with 1.64% genetic variance; chromosome 18, Mb 9 with 1.01% genetic variance
Fig. 3 Manhattan plot for 1-Mb windows for Bovine viral diarrhea virus type 1 overall vaccination response. A Manhattan plot showing every 1-
Mb window by %variance accounted for by that window across the entire Bos taurus genome. Two singular windows exceeded the 1% genetic
variance threshold: chromosome 4, Mb 12 with 1.93% genetic variance; chromosome 29, Mb 32 with 1.15% genetic variance
Kramer et al. BMC Genetics            (2019) 20:6 Page 4 of 10
neutralization antibody level and response to vaccination
traits were lowly to moderately heritable. Ranging from
0.08 to 0.22, we determined that the heritability of viral
neutralization antibody level and response to vaccination
traits varied the most in BVDV1 and BVDV2, and the
least in BRSV. However, when only traits measured on
all four viruses are compared, BVDV1 and BVDV2 have
a much more concentrated range in heritabilities than
the other two. Additionally, as described in Kramer et al.
2017, BRSV was the singular virus out of the four stud-
ied that did not contain individual calves that failed to
seroconvert, potentially due to the ubiquitous nature of
BRSV [16, 19]. This represented a smaller range in the
titer sample data and may impact its ability to be com-
pared to the other three viruses. Heritability estimates
for immune related traits in other studies range from
Fig. 4 Manhattan plot for 1-Mb windows for Bovine viral diarrhea virus type 2 booster vaccination response. A Manhattan plot showing every 1-
Mb window by %variance accounted for by that window across the entire Bos taurus genome. One window exceeded the 1% genetic variance
threshold: chromosome 27, Mb 16 with 1.03% genetic variance
Fig. 5 Manhattan plot for 1-Mb windows for Bovine respiratory syncytial virus overall vaccination response. A Manhattan plot showing every 1-
Mb window by %variance accounted for by that window across the entire Bos taurus genome. One window exceeded the 1% genetic variance
threshold: chromosome 1, Mb 144 with 1.03% genetic variance
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lowly (0.11) to highly heritable (0.47), dependent on the
immune trait evaluated, whether it is due to a infectious
challenge or vaccination, and species [20–24]. The herit-
ability estimates based on estimated direct genetic vari-
ation are on the lower end of this previously found
range. This is likely due to response to vaccination as a
complex trait with many non-genetic influences as noted
in Kramer et al. 2017, and will make selection for these
antibody titer level and response to vaccination traits
slower than if they were more heritable.
Low correlations were calculated between direct genetic
value and the true phenotype, with a range of − 0.10 to
0.09. Accuracies also ranged from an absolute value of
0.002 to 0.31. These accuracies are a direct result of low
heritabilities as accuracy was calculated as correlation di-
vided by the square root of heritability. While the correl-
ation between true and predicted phenotype is low, and
accuracies are on average 0.11, some traits such as BHV1
overall vaccination response and BVDV1 final titer may
have a level of accuracy such that they could be utilized in
a selection index. These determined correlations and accur-
acies underscore the point that responses to vaccination
traits remain complicated even after fitting management
practices and other environmental and physiological factors
in a model. With a greater number of individuals, it may be
possible to improve the accuracy closer to its maximum, al-
though it will be capped by the heritability estimates of re-
sponse to vaccination traits (0.28–0.45 range for
maximums). If accuracies of genomic predictions can be in-
creased towards these maximums, then the rate of genetic
progress for response to vaccination and viral neutralization
antibody level traits will increase.
These traits appear to be highly polygenic, as no singular
region was able to account for a large proportion of genetic
variation and only six regions were estimated to account
for more than 1% of that variation (Figs. 2, 3, 4, 5). The
polygenic nature of viral neutralization antibody level, re-
sponse to vaccination, and immune related traits is some-
thing that has been previously reported in numerous
studies such as those focused on porcine [17, 25], chicken
[26, 27], cattle [28–31], and mice [32]. In the six windows
that accounted for more than 1% of the genetic variance in
this study, no candidate genes were identified as none of
the genes in those regions were annotated with Gene
Ontology terms associated with immune response func-
tions. The TRIM gene family is present, however, and may
have some further functional relevance that is not currently
described in published literature [18].
Conclusions
This study aimed to examine response to vaccination
against viruses associated with BRDC in Angus calves
using genome wide association studies. Vaccination is one
of the most widely used tools by producers to reduce and/
or prevent BRDC incidence in herds. Efficacy remains
lower than desired; therefore selection of cattle for re-
sponse to vaccination could increase the effectiveness of
vaccine use. This would potentially reduce losses associ-
ated with BRDC and improve animal welfare. Using serum
samples across a 6–9 week period we were able to identify
genomic regions associated with multiple response to vac-
cination traits, and determine the predictive accuracy of
response to vaccination. Windows of size 1-Mb were
found to account for up to 1.93% of genetic variation, in-
dicating the polygenic nature of response to vaccination.
With low to moderate heritabilities across response to
vaccination traits, there appears to be room for selection
of animals with improved vaccination response. Genes
within the associated regions had little functional annota-
tion associated with them, which may be resolved in
future builds of the Bos taurus genome along with the
help of the Functional Annotation of Animal Genomes
(FAANG) initiative. All of this together provides a solid
foundation for genetic variation within response to vac-
cination in Angus calves, and a basis for selection
procedures.
Table 3 Categorical analysis posterior estimates of genetic (σg2)
and residual (σe2) variance, and heritability (h2)
Virus Traita σg
2 σe
2 h2
BVDV1 Maternal Antibody Titerb 0.33 1.00 0.25
Initial Vaccination 0.22 1.00 0.18
Initial Vaccination Response 0.22 1.00 0.18
Booster Vaccination Response 0.15 1.00 0.13
Overall Vaccination Response 0.16 1.00 0.14
Final Titer 0.52 1.00 0.34
BVDV2 Maternal Antibody Titerb 0.24 1.00 0.19
Initial Vaccination 0.15 1.00 0.13
Initial Vaccination Response 0.11 1.00 0.10
Booster Vaccination Response 0.11 1.00 0.10
Overall Vaccination Response 0.11 1.00 0.10
Final Titer 0.27 1.00 0.21
BRSV Initial Vaccination 0.61 1.00 0.38
Initial Vaccination Response 0.17 1.00 0.14
Booster Vaccination Response 0.51 1.00 0.34
Overall Vaccination Response 0.29 1.00 0.23
Final Titer 0.47 1.00 0.32
BHV1 Initial Vaccination 0.61 1.00 0.38
Initial Vaccination Response 0.14 1.00 0.12
Booster Vaccination Response 0.14 1.00 0.13
Overall Vaccination Response 0.15 1.00 0.13
Final Titer 0.51 1.00 0.34
aAll trait titers measured in log2 transformations from serum
neutralization dilutions
bMaternal antibody titer data only available for BVDV1 and BVDV2
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Methods
Population
Calves (n = 2518) from a purebred American Angus herd
located at Iowa State University Ames, IA, were used in
this study. Not all individuals were utilized for all re-
sponse to vaccination traits due to limited availability of
recorded data at specific time points and non-genotyped
calves. Therefore, the number of calves analyzed for each
response to vaccination trait was less than the total
number of genotyped calves. Calves were born in either
a spring season or fall season classification, and across
multiple years (2006–2012, 2014).
Phenotypic data
Phenotypic data was collected as described in previous
work [13–15]. Briefly; individuals were vaccinated with a
modified live vaccine (Bovi-Shield Gold 5, Zoetis, Inc.
Parsippany NJ). Serum samples were collected from the
calves at multiple time points and then a viral
neutralization assay was performed for each sample to
quantify the level of antibodies present against one of four
viruses (BVDV1, BVDV2, BRSV, BHV1). Dilutions were
performed to identify the greatest dilution where neutral-
izing antibodies could still be detected, and a log2 titer
was recorded. This was based on the Spearman-Kärber
method for initial calculation [33]. Response traits were
calculated as the change in titer values between serum
sample collection time points (initial, booster, and overall
vaccination response), or as the calculated titer value for a
given time (maternal, initial, and final antibody titer).
Genotypic data
The BovineSNP50 BeadChip (Illumina, San Diego, CA)
and BovineHD BeadChip (Illumina, San Diego, CA)
were used by Neogen GeneSeek Operations (Lincoln,
NE) to perform SNP genotyping. Individuals were im-
puted by using the SNPipeline package (Hailin Su,
https://github.com/cbkmephisto/SNPipeline) and FIm-
pute [34] from the BovineSNP50 BeadChip to the Bovi-
neHD BeadChip using 820 Angus individuals genotyped
Table 4 Number of individuals for each K Means group within response to vaccination trait
K Means Groups Total
Virus Traita 1 2 3 4 5
BVDV1 Maternal Decayb 131 89 126 90 133 569
Maternal Antibody Titerb 130 88 125 90 133 566
Initial Vaccination 314 289 306 290 319 1518
Initial Vaccination Response 244 236 253 234 273 1240
Booster Vaccination Response 211 214 213 208 245 1091
Overall Vaccination Response 198 187 210 206 243 1044
Final Titer 234 236 238 240 281 1229
BVDV2 Maternal Decayb 198 194 150 161 192 895
Maternal Antibody Titerb 232 210 185 195 227 1049
Initial Vaccination 408 353 291 354 332 1738
Initial Vaccination Response 426 353 314 371 351 1815
Booster Vaccination Response 425 350 313 371 347 1806
Overall Vaccination Response 424 350 312 372 347 1805
Final Titer 425 350 312 372 347 1805
BRSV Initial Vaccination 312 285 312 281 318 1508
Initial Vaccination Response 268 217 248 230 246 1209
Booster Vaccination Response 250 200 230 214 222 1116
Overall Vaccination Response 286 256 273 252 270 1337
Final Titer 287 263 276 261 280 1367
BHV1 Initial Vaccination 312 283 301 280 315 1491
Initial Vaccination Response 312 285 302 281 318 1498
Booster Vaccination Response 254 230 243 218 234 1179
Overall Vaccination Response 256 236 253 226 245 1216
Final Titer 257 244 256 234 254 1245
aAll trait titers measured in log2 transformations from serum neutralization dilutions. Maternal Decay measured as log2 titer change per day
bMaternal Decay and Maternal antibody titer data only available for BVDV1 and BVDV2
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natively for the Bovine HD BeadChip, both within and
outside the ISU herd. Accuracy of imputation was about
97%, and was tested by randomly removing 5000
markers from the 50 k genotype, and then comparing
imputed genotypes of these 5000 markers to the original
genotypes. 574,662 single nucleotide polymorphisms
(SNPs) remained after editing for a minor allele fre-
quency (MAF) of 0.05. All SNPs were assigned a
UMD3.1 bovine genome build position [35].
Statistical model
All 574,662 SNPs were used alongside phenotypic titer
measurements or differences to determine an estimate
of each SNP effect for a respective trait. Single SNP ef-
fect estimates were obtained using BayesB approach
through the program GenSel [36]. This method assumes
a model in which a portion of SNP markers have zero
effect on a trait, denoted as a π, and markers not
assigned zero effect are used in prediction by estimating
individual SNP effects. Models were generally fit as
follows:
y ¼ Xbþ Zuþ e
where y was a vector of response to vaccination trait ob-
servations; b is a set of vectors of fixed effects; u is a vec-
tor of SNPS as random effects sampled through BayesB;
and e was the remaining vector of residuals correspond-
ing to each phenotypic record [37]. Fixed effects and Co-
variates are explained in detail within, but included the
fixed effects of: Year-Season classification, Sex, Dam
Age, Weaned Status, Pink Eye Status; covariates of Calf
Age within Year-Season classification, Titer score,
Titer-by-Titer score, and Average Daily Gain [13]. A π
value of 0.999 was used for BayesB [38] analysis of each
trait (approximately 575 SNP markers with a non-zero
effect), while genetic and residual variances for each trait
were estimated using BayesC (initial variances set as half
the total phenotypic variance) before being used in
BayesB [37, 39]. A total of 50,000 iterations were used
with Monte Carlo Markov Chain, with the first 5000
thrown out as a burn in, to obtain posterior means of
SNP marker effects and posterior probabilities of
inclusion.
BayesB analysis outputs included SNP marker effect
estimates, 1-Mb window effect estimates, and a direct
genetic value prediction for every individual. Each SNP
marker and 1-Mb window was estimated a % genetic
variance that it accounted for, and a posterior probability
of inclusion to indicate the frequency in which it was in-
cluded in the BayesB analysis.
Response to vaccination and viral titer level traits were
also analyzed as categorical traits in addition to the
above analysis, and models for these traits as categorical
were fit and run as above. Phenotypes were set as the
truncated integer value for a recorded phenotypic meas-
urement (1.0–1.99 = 1, etc.…) rather than rounding to
integer values. All other fixed effects, covariates, and the
matrix of random marker effects remained the same.
Heritability
Heritability estimates for each trait were obtained
through BayesC with a π value of 0. This was chosen
due to BayesB shrinking small effects to allow for the de-
tection of relatively larger effects, and therefore biasing
heritability estimates [37, 39]. Heritability was calculated
as the posterior genetic variance over the total estimated
posterior phenotypic variance.
Accuracy of prediction
Prediction accuracies were estimated through cross valid-
ation for the direct genetic values that were predicted for
each individual in BayesC. Genotyped individuals were
Table 5 Pooled correlation between phenotype and predicted
direct genetic value, and accuracy of prediction
Virus Traita Correlation Accuracyb
BVDV1 Maternal Antibody Titerc 0.02 0.04
Initial Vaccination 0.06 0.12
Initial Vaccination Response 0.02 0.05
Booster Vaccination Response 0.08 0.19
Overall Vaccination Response 0.09 0.22
Final Titer 0.09 0.22
BVDV2 Maternal Antibody Titerc − 0.05 0.15
Initial Vaccination −0.02 0.08
Initial Vaccination Response 0.04 0.15
Booster Vaccination Response −0.01 0.03
Overall Vaccination Response 0.00 0.00
Final Titer −0.03 0.11
BRSV Initial Vaccination 0.07 0.22
Initial Vaccination Response 0.00 0.01
Booster Vaccination Response −0.05 0.11
Overall Vaccination Response 0.00 0.01
Final Titer 0.01 0.04
BHV1 Initial Vaccination 0.02 0.05
Initial Vaccination Response 0.05 0.13
Booster Vaccination Response 0.01 0.03
Overall Vaccination Response −0.10 0.31
Final Titer − 0.06 0.19
aAll trait titers measured in log2 transformations from serum
neutralization dilutions
bAccuracy calculated as correlation between direct genetic value and
phenotype divided by square root of heritability
cMaternal antibody titer data only available for BVDV1 and BVDV2
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initially classified into 9 unequal groups through K-means
clustering [40] after creating a genomic relationship
matrix [41]. Using this method, each group was made to
be as genetically similar as possible within group, while
remaining genetically distinct to the other 8 groups.
Through this, groups can be used as predictors of other
groups due to genetic similarity. The 9 initial groups were
clustered down to 5 total groups by merging numerically
smaller groups together so that groups were more consist-
ently sized. BayesC with a π value of 0 was used to per-
form training and validation for these groups as follows: 1
group was excluded from the BayesC π = 0 analysis, and
direct genetic values were calculated on the remaining 4
groups of animals. Those single SNP marker estimates
were then used validate the final 5th group. Each group
was rotated so that every individual was validated once
and used as training set four times. Accuracy was calcu-
lated by taking the correlation between predicted direct
genetic value and phenotypes for all individuals in a given
trait divided by the square root of heritability for that trait.
Candidate gene identification
The 1-Mb genomic regions accounting for more than
1% OF genetic variation for response to vaccination
traits were identified for candidate gene investigation. A
region extending half a mega base on either side of the
identified 1-Mb regions, for a total of 2Mb in length,
was analyzed by looking at the biological function of
every gene currently annotated in the UMD 3.1 Bos
taurus assembly of the genome.
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